BMC Research Notes (Oct 2023)

Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto’s thyroiditis

  • Marowa N. Hamad,
  • Fuodat I. Mohamed,
  • Mayada M. Osman,
  • Ahlam A. Jadid,
  • Ibtihal K. Abdalrhman,
  • Alaa M. Yousif,
  • Tyseer Alabid,
  • Ali Mahmoud Mohammed Edris,
  • Nouh S. Mohamed,
  • Emmanuel Edwar Siddig,
  • Ayman Ahmed

DOI
https://doi.org/10.1186/s13104-023-06399-8
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Objectives Hashimoto’s thyroiditis (HT) is the most common cause of hypothyroidism. The exact mechanism initiating the development of HT is not yet clear. This study aimed to investigate the correlation between HT and the presence of Epstein-Barr virus (EBV) in a Sudanese population. Results EBV-LMP1 was detected in 11.1% of HT cases, which is consistent with previous studies. Studies have reported a wide range of frequencies indicating the presence of EBV in HT, and patients with autoimmune thyroiditis have increased titers of anti-EBV antibodies in their sera compared to healthy subjects. Intrathyroidal EBV-infected B cells may be responsible for the increased risk of development of B-cell lymphoma in the thyroid gland in patients with autoimmune thyroiditis. Our study suggests that regular follow-up is necessary for patients diagnosed with HT and are positive for EBV, as antiviral therapy is not applicable due to the risk of thyroid dysfunction. The study suggests an association between EBV and HT, but causation cannot be determined. The study also highlights the need for further research to determine the viral role and correlate it with the severity and progression of HT.

Keywords